Marcum Wealth LLC grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 67.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,183 shares of the pharmacy operator’s stock after acquiring an additional 2,881 shares during the period. Marcum Wealth LLC’s holdings in Walgreens Boots Alliance were worth $322,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also bought and sold shares of the company. Wellington Management Group LLP raised its position in shares of Walgreens Boots Alliance by 21.3% during the 3rd quarter. Wellington Management Group LLP now owns 6,396 shares of the pharmacy operator’s stock worth $301,000 after purchasing an additional 1,121 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in Walgreens Boots Alliance by 12.5% in the third quarter. Thrivent Financial for Lutherans now owns 39,066 shares of the pharmacy operator’s stock valued at $1,877,000 after acquiring an additional 4,326 shares during the last quarter. Patriot Financial Group Insurance Agency LLC lifted its position in Walgreens Boots Alliance by 146.2% in the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 682 shares of the pharmacy operator’s stock valued at $36,000 after acquiring an additional 405 shares during the last quarter. DNB Asset Management AS lifted its position in Walgreens Boots Alliance by 6.3% in the fourth quarter. DNB Asset Management AS now owns 167,743 shares of the pharmacy operator’s stock valued at $8,749,000 after acquiring an additional 9,914 shares during the last quarter. Finally, Heartwood Wealth Advisors LLC raised its position in Walgreens Boots Alliance by 11.8% in the fourth quarter. Heartwood Wealth Advisors LLC now owns 6,901 shares of the pharmacy operator’s stock valued at $360,000 after acquiring an additional 730 shares during the last quarter. Institutional investors and hedge funds own 57.02% of the company’s stock.
Shares of NASDAQ WBA opened at $38.56 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $36.97 and a 12-month high of $55.00. The company has a market capitalization of $33.31 billion, a PE ratio of 5.32, a price-to-earnings-growth ratio of 1.65 and a beta of 0.55. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.74 and a quick ratio of 0.35. The firm’s 50-day moving average is $42.29 and its two-hundred day moving average is $46.45.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last announced its quarterly earnings results on Thursday, June 30th. The pharmacy operator reported $0.96 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.96. Walgreens Boots Alliance had a net margin of 4.62% and a return on equity of 19.15%. The company had revenue of $32.60 billion for the quarter, compared to the consensus estimate of $32.23 billion. During the same quarter in the previous year, the firm earned $1.51 earnings per share. The company’s revenue for the quarter was down 4.2% compared to the same quarter last year. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 5.06 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, June 10th. Shareholders of record on Friday, May 20th were issued a $0.4775 dividend. This represents a $1.91 annualized dividend and a dividend yield of 4.95%. The ex-dividend date of this dividend was Thursday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 26.34%.
A number of equity research analysts recently weighed in on the stock. Barclays reduced their price target on shares of Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating for the company in a research report on Friday, June 24th. UBS Group reduced their price target on shares of Walgreens Boots Alliance from $52.00 to $49.00 and set a “neutral” rating for the company in a research report on Tuesday, April 5th. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $50.00 to $42.00 and set a “hold” rating for the company in a report on Friday. StockNews.com cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Friday. Finally, Robert W. Baird lowered shares of Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and dropped their price target for the stock from $70.00 to $51.00 in a research note on Friday, April 1st. One investment analyst has rated the stock with a sell rating and ten have given a hold rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $48.23.
In related news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 11th. The shares were sold at an average price of $150.00, for a total transaction of $900,000,000.00. Following the transaction, the insider now owns 52,854,867 shares of the company’s stock, valued at $7,928,230,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 17.40% of the company’s stock.
Walgreens Boots Alliance Profile: (Get Rating)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumables, and general merchandise products through its retail drugstores.
Recommended Stories:
Receive News & Ratings for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s FREE daily email newsletter.
.